“We believe the strong patient protections in Part D will help everyone get access to the drugs that are right for them at a lower cost,” Mr Azar said during a recent speech, “but we want your input on how that should work.”
In an attempt to decrease transmission of HIV and end the current epidemic, major stakeholders are taking steps to increase availability of pre-exposure prophylaxis, although some plans still deny coverage.
According to a new study published online in The New England Journal of Medicine, a humanized IgG4 monoclonal antibody that binds to CD4 extracellular domain 2 reduced viral load in patients with multidrug-resistant HIV-1.
According to a new study published in the New England Journal of Medicine, patients with HIV covered by Medicaid who had medical comorbidities and behavioral health disorders had fewer inpatient services, more outpatient services, and overall lower costs when treated in a patient-centered medical home.
A humanized immunoglobulin G4 monoclonal antibody improved antiviral activity among patients with multidrug-resistant HIV-1, according to a new study published in The New England Journal of Medicine.